Hajime Kamijuku Selected Research

ACT regimen

8/2021

Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hajime Kamijuku Research Topics

Disease

3	Neoplasms (Cancer) 08/2021 - 12/2010
1	Fever (Fevers) 08/2021
1	Leukopenia 08/2021
1	Melanoma (Melanoma, Malignant) 08/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Neoplasm Metastasis (Metastasis) 12/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2010
1	Pathologic Processes 12/2009
1	Eosinophilia 01/2007
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2007
1	Asthma (Bronchial Asthma) 01/2007

Drug/Important Bio-Agent (IBA)

2	ChemokinesIBA 08/2021 - 05/2013
2	CytokinesIBA 05/2013 - 01/2007
1	Immune Checkpoint InhibitorsIBA 08/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2021
1	CateninsIBA 08/2021
1	Galactosylceramides (Galactocerebrosides)IBA 12/2010
1	IonsIBA 12/2010
1	CarbonIBA 12/2010
1	Phospholipases (Phospholipase)IBA 12/2009
1	CalciumIBA 12/2009
1	Calcium-Independent Phospholipases A2IBA 12/2009
1	Interleukin-13IBA 01/2007
1	Thymic Stromal LymphopoietinIBA 01/2007
1	Immunoglobulin E (IgE)IBA 01/2007
1	AntigensIBA 01/2007
1	AllergensIBA 01/2007

Therapy/Procedure

2	Therapeutics 08/2021 - 05/2013
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2021
1	ACT regimen 08/2021
1	Hematopoietic Stem Cell Transplantation 01/2020
1	Immunotherapy 05/2013
1	Molecular Targeted Therapy 05/2013
1	Heavy Ion Radiotherapy 12/2010